|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 9111 |
FusionGeneSummary for CYBA_ST3GAL2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CYBA_ST3GAL2 | Fusion gene ID: 9111 | Hgene | Tgene | Gene symbol | CYBA | ST3GAL2 | Gene ID | 1535 | 6483 |
| Gene name | cytochrome b-245 alpha chain | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 | |
| Synonyms | p22-PHOX | Gal-NAc6S|SIAT4B|ST3GALII|ST3GalA.2 | |
| Cytomap | 16q24.2 | 16q22.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cytochrome b-245 light chaincytochrome b light chaincytochrome b(558) alpha chaincytochrome b(558) alpha-subunitcytochrome b, alpha polypeptidecytochrome b-245, alpha polypeptidecytochrome b558 subunit alphaflavocytochrome b-558 alpha polypeptiden | CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferaseSIAT4-BST3Gal IIalpha 2,3-ST 2beta-galactoside alpha-2,3-sialyltransferase 2sialyltransferase 4B (beta-galactosidase alpha-2,3-sia | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P13498 | Q16842 | |
| Ensembl transtripts involved in fusion gene | ENST00000261623, ENST00000567174, ENST00000569359, ENST00000561972, | ENST00000342907, ENST00000393640, ENST00000566097, | |
| Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 6 X 5 X 5=150 |
| # samples | 3 | 6 | |
| ** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(6/150*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CYBA [Title/Abstract] AND ST3GAL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CYBA | GO:0017004 | cytochrome complex assembly | 7938008 |
| Hgene | CYBA | GO:0032755 | positive regulation of interleukin-6 production | 22423966 |
| Hgene | CYBA | GO:0032760 | positive regulation of tumor necrosis factor production | 22423966 |
| Hgene | CYBA | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 22423966 |
| Hgene | CYBA | GO:0050766 | positive regulation of phagocytosis | 22423966 |
| Hgene | CYBA | GO:1900426 | positive regulation of defense response to bacterium | 22423966 |
| Hgene | CYBA | GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | 22423966 |
| Tgene | ST3GAL2 | GO:0006486 | protein glycosylation | 9266697 |
| Tgene | ST3GAL2 | GO:0009101 | glycoprotein biosynthetic process | 9266697 |
| Tgene | ST3GAL2 | GO:0009247 | glycolipid biosynthetic process | 9266697 |
| Tgene | ST3GAL2 | GO:0009312 | oligosaccharide biosynthetic process | 9266697 |
| Tgene | ST3GAL2 | GO:0030259 | lipid glycosylation | 9266697 |
| Tgene | ST3GAL2 | GO:0097503 | sialylation | 9266697 |
| Tgene | ST3GAL2 | GO:1990743 | protein sialylation | 9266697 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BC048338 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000261623 | ENST00000342907 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-3UTR | ENST00000261623 | ENST00000393640 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-intron | ENST00000261623 | ENST00000566097 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-3UTR | ENST00000567174 | ENST00000342907 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-3UTR | ENST00000567174 | ENST00000393640 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-intron | ENST00000567174 | ENST00000566097 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| 5CDS-3UTR | ENST00000569359 | ENST00000342907 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| 5CDS-3UTR | ENST00000569359 | ENST00000393640 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| 5CDS-intron | ENST00000569359 | ENST00000566097 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-3UTR | ENST00000561972 | ENST00000342907 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-3UTR | ENST00000561972 | ENST00000393640 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
| intron-intron | ENST00000561972 | ENST00000566097 | CYBA | chr16 | 88711495 | - | ST3GAL2 | chr16 | 70413581 | - |
Top |
FusionProtFeatures for CYBA_ST3GAL2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CYBA | ST3GAL2 |
| Critical component of the membrane-bound oxidase ofphagocytes that generates superoxide. Associates with NOX3 to forma functional NADPH oxidase constitutively generating superoxide.{ECO:0000269|PubMed:15824103}. | Responsible for the synthesis of the sequence NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- found in terminal carbohydrategroups of certain glycoproteins, oligosaccharides and glycolipids.SIAT4A and SIAT4B sialylate the same acceptor substrates butexhibit different Km values. {ECO:0000250|UniProtKB:Q11204}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CYBA_ST3GAL2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CYBA_ST3GAL2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CYBA_ST3GAL2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CYBA_ST3GAL2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CYBA | C1856255 | Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative | 5 | CTD_human;UNIPROT |
| Hgene | CYBA | C0020538 | Hypertensive disease | 3 | CTD_human |
| Hgene | CYBA | C0011853 | Diabetes Mellitus, Experimental | 2 | CTD_human |
| Hgene | CYBA | C0004153 | Atherosclerosis | 1 | CTD_human |
| Hgene | CYBA | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| Hgene | CYBA | C0018203 | Chronic granulomatous disease | 1 | CTD_human;ORPHANET |
| Hgene | CYBA | C0018799 | Heart Diseases | 1 | CTD_human |
| Hgene | CYBA | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
| Hgene | CYBA | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| Hgene | CYBA | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | CYBA | C1565489 | Renal Insufficiency | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|